Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for Cardiovascular Function in Severe Thyrotoxicosis
NCT02767245Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jan 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of thiamine in thyrotoxicosis (2 arms), sponsored by Ramathibodi Hospital. Primary endpoint: Left Ventricular Systolic Function at 3 months. Started Jan 2014; status: completed.
02
Drugs
thiamine
03
Conditions
thyrotoxicosis
Beyond the preview
Go deeper on NCT02767245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767245.